Review
doi: 10.2522/ptj.20070104.
Epub 2007 Nov 6.
Facioscapulohumeral dystrophy
Affiliations
- PMID: 17986494
- DOI: 10.2522/ptj.20070104
Item in Clipboard
Review
Facioscapulohumeral dystrophy
Phys Ther.
2008 Jan.
Abstract
Facioscapulohumeral dystrophy (FSHD) is the third most common inherited muscular dystrophy after Duchenne dystrophy and myotonic dystrophy. Over the last decade, major advances have occurred in the understanding of the genetics of this disorder. Despite these advances, the exact mechanisms that lead to atrophy and weakness secondary to the genetic defect are still not understood. The purposes of this article are to increase awareness of FSHD among clinicians; to provide an update regarding the genetics, clinical features, natural history, and current management of FSHD; and to discuss opportunities for research.
Similar articles
-
Facioscapulohumeral muscular dystrophy.Neurotherapeutics. 2008 Oct;5(4):601-6. doi: 10.1016/j.nurt.2008.07.005. Neurotherapeutics. 2008. PMID: 19019312 Free PMC article. Review.
-
Severe phenotype in infantile facioscapulohumeral muscular dystrophy.Neuromuscul Disord. 2006 Oct;16(9-10):553-8. doi: 10.1016/j.nmd.2006.06.008. Epub 2006 Aug 24. Neuromuscul Disord. 2006. PMID: 16934468
-
Molecular diagnosis of facioscapulohumeral muscular dystrophy.Expert Rev Mol Diagn. 2002 Mar;2(2):160-71. doi: 10.1586/14737159.2.2.160. Expert Rev Mol Diagn. 2002. PMID: 11962336 Review.
-
[Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Oct;18(5):398-401. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001. PMID: 11592052 Review. Chinese.
-
Facioscapulohumeral dystrophy.Semin Neurol. 1999;19(1):35-43. doi: 10.1055/s-2008-1040824. Semin Neurol. 1999. PMID: 10711987 Review.
Cited by
-
Nutritional Status of Patients with Facioscapulohumeral Muscular Dystrophy.Nutrients. 2023 Mar 30;15(7):1673. doi: 10.3390/nu15071673. Nutrients. 2023. PMID: 37049513 Free PMC article.
-
Anticipation Avoids Adversity: Anesthetic Management of a Case of Facioscapulohumeral Dystrophy (FSHD).Cureus. 2023 Jan 31;15(1):e34442. doi: 10.7759/cureus.34442. eCollection 2023 Jan. Cureus. 2023. PMID: 36733549 Free PMC article.
-
CRISPR mediated targeting of DUX4 distal regulatory element represses DUX4 target genes dysregulated in Facioscapulohumeral muscular dystrophy.Sci Rep. 2021 Jun 15;11(1):12598. doi: 10.1038/s41598-021-92096-0. Sci Rep. 2021. PMID: 34131248 Free PMC article.
-
DUX Hunting-Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia.Cancers (Basel). 2020 Sep 30;12(10):2815. doi: 10.3390/cancers12102815. Cancers (Basel). 2020. PMID: 33007870 Free PMC article. Review.
-
The development of myasthenia gravis in a patient with facioscapulohumeral muscular dystrophy: case report and literature review.Neurol Int. 2019 Jun 19;11(3):8191. doi: 10.4081/ni.2019.8191. eCollection 2019 Sep 18. Neurol Int. 2019. PMID: 31579125 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
